日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

PRognostic and predictive potential Of multiparametric dynamic whole-body 18F-FDG PET Imaging using a Long axial field-of-view (LAFOV) system for FIRST-line chemo-immunotherapy efficacy in advanced non-small cell lung cancer: PROFIL-1 study protocol

采用长轴视野（LAFOV）系统进行多参数动态全身18F-FDG PET成像对晚期非小细胞肺癌一线化疗-免疫疗法疗效的预后和预测潜力：PROFIL-1研究方案

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0345990
Geier, Margaux; Amrane, Karim; Bourhis, David; Le Roux, Pierre-Yves; Nguyen, Jessica; Dhamelincourt, Estelle; Descourt, Renaud; Quéré, Gilles; Guegan, Marie; Besse, Benjamin; Déandreis, Désirée; Besson, Florent; Faure, Sylvain; Karakatsanis, Nicolas; Salaun, Pierre-Yves; Pavoine, Mathieu; Bourbonne, Vincent; Lucia, François; Abgral, Ronan
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysis

一线治疗晚期肺肉瘤样癌的疗效：一项真实世界分析

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105343
Amrane, K; Cabarrou, B; Justeau, G; Schneider, S; Quantin, X; Falchero, L; Bigot, F; Ferrari, V; Guisier, F; Girard, N; Lena, H; Dansin, E; Madroszyk, A; Bizieux, A; Debieuvre, D; Perol, M; Simoneau, Y; Bosquet, L; Descourt, R; Chouaïd, C
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Survival impact of a KEAP1-NFE2L2 radiomics model in PDL1 ≥ 50% non-small cell lung cancer treated with pembrolizumab: the PEMBROMIC study

KEAP1-NFE2L2放射组学模型对PD-L1≥50%非小细胞肺癌患者接受帕博利珠单抗治疗的生存影响：PEMBROMIC研究

期刊:Cancer Imaging
影响因子:3.5
doi:10.1186/s40644-025-00957-y
Le Meur, Coline; Amrane, Karim; Descourt, Renaud; Chasseray, Matthieu; Pradier, Olivier; Bourhis, David; Abgral, Ronan; Bourbonne, Vincent
KEAP1
肺癌
肿瘤
肿瘤免疫
PD-L1
细胞生物学
发表日期：2025
文献求助 收藏

Alectinib Efficacy Post-Brigatinib Against Advanced ALK+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study)

阿来替尼在布加替尼治疗后对晚期ALK+非小细胞肺癌的疗效（BrigALK2-GFPC 02-2019研究）

期刊:Lung Cancer: Targets and Therapy
影响因子:3.3
doi:10.2147/LCTT.S522038
Descourt, Renaud; Guisier, Florian; Pérol, Maurice; Cadranel, Jacques; Doubre, Helene; Duruisseaux, Michael; Culine, Stéphane; Mennecier, Bertrand; Bylicki, Olivier; Chouaid, Christos; Greillier, Laurent
肺癌
肿瘤
肿瘤免疫
ALK
GFP
细胞生物学
发表日期：2025
文献求助 收藏

Patterns of Treatment and Real-World Outcomes of Patients With Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations Receiving Mobocertinib: The EXTRACT Study

接受莫博替尼治疗的EGFR 20号外显子插入突变非小细胞肺癌患者的治疗模式和真实世界结果：EXTRACT研究

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.70369
Liu, Geoffrey; Nyaw, Shi Feng; Mok, Tony S K; Curcio, Hubert; Cortot, Alexis B; Kam, Tsz Yeung; Descourt, Renaud; Chik, Yin Kwan; Cheema, Parneet; Gwinnutt, James M; Churchill, Eric N; Nyborn, Justin; Curran, Eileen; Savell, Alexandra; Yin, Yu; Chong, Katie; Tanaka-Chambers, Yuka; Kretz, Julian; Cadranel, Jacques
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2025
文献求助 收藏

Uncommon MET mutational landscape in a non-small cell lung cancer patient treated with crizotinib: Case report

克唑替尼治疗非小细胞肺癌患者中罕见的MET突变图谱：病例报告

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2024.e31944
Geier, Margaux; Nguyen, Jessica; Dhamelincourt, Estelle; Babey, Hélène; Descourt, Renaud; Quéré, Gilles; Robinet, Gilles; Lucia, François; Pacault, Mathilde
肺癌
肿瘤
肿瘤免疫
细胞生物学
MET
发表日期：2024
文献求助 收藏

Real-life clinical management patterns in extensive-stage small cell lung cancer across France: a multi-method study

法国广泛期小细胞肺癌的真实临床管理模式：一项多方法研究

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-024-12117-9
Mennecier, Bertrand; Khalifa, Jonathan; Descourt, Renaud; Greillier, Laurent; Naltet, Charles; Falchero, Lionel
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study)

一线单药帕博利珠单抗治疗 PD-L1 阳性（肿瘤比例评分 ≥ 50%）晚期非小细胞肺癌的真实世界研究：对脑转移的影响：一项法国全国多中心队列研究（ESCKEYP GFPC 研究）

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-022-03232-2
Descourt, Renaud; Greillier, Laurent; Perol, Maurice; Ricordel, Charles; Auliac, Jean-Bernard; Falchero, Lionel; Gervais, Radj; Veillon, Rémi; Vieillot, Sabine; Guisier, Florian; Marcq, Marie; Justeau, Grégoire; Bigay-Game, Laurence; Bernardi, Marie; Fournel, Pierre; Doubre, Hélène; Pinsolle, Julian; Amrane, Karim; Chouaïd, Christos; Decroisette, Chantal
肺癌
肿瘤
肿瘤免疫
神经科学
GFP
PD-L1
细胞生物学
发表日期：2023
文献求助 收藏

Pembrolizumab plus pemetrexed-carboplatin combination in first-line treatment of advanced non-squamous non-small cell lung cancer: a multicenter real-life study (CAP29)

帕博利珠单抗联合培美曲塞-卡铂一线治疗晚期非鳞状非小细胞肺癌：一项多中心真实世界研究（CAP29）

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-22-556
Renaud, Emmanuelle; Ricordel, Charles; Corre, Romain; Leveiller, Guillaume; Gadby, Florence; Babey, Hélène; Annic, Josselin; Lucia, François; Bourbonne, Vincent; Robinet, Gilles; Descourt, Renaud; Orione, Charles; Quéré, Gilles; Geier, Margaux
肺癌
肿瘤
肿瘤免疫
CAP2
细胞生物学
发表日期：2023
文献求助 收藏

Incidence of venous thromboembolism and association with PD-L1 expression in advanced non-small cell lung cancer patients treated with first-line chemo-immunotherapy

一线化疗联合免疫疗法治疗晚期非小细胞肺癌患者中静脉血栓栓塞的发生率及其与PD-L1表达的相关性

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1221106
Aguiar De Azevedo, Liliana; Orione, Charles; Tromeur, Cécile; Couturaud, Francis; Descourt, Renaud; Geier, Margaux
肺癌
肿瘤
肿瘤免疫
心血管
PD-L1
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏